Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Molecular Characterization of Diffuse Large B-Cell Lymphoma Associated to Hepatitis C Virus Infection

Blood (2021) 138 (Supplement 1): 2402.

https://doi.org/10.1182/blood-2021-152636

Published: 2021

Journal Articles

Cell-of-Origin Identification and Prognostic Correlation in HIV-Associated Diffuse Large B-Cell Lymphomas: Results of an Italian Multicentric Study

Blood (2018) 132 (Supplement 1): 5294.

https://doi.org/10.1182/blood-2018-99-116437

Published: 2018

Journal Articles

A Phase II Study of Brentuximab Vedotin (BV) in the Treatment of Elderly Hodgkin Lymphoma (HL) Patients at First Relapse or with Primary Refractory Disease — FIL_BVHD01

Lorenzo Tonialini, MD, Vittorio Stefoni, Alessandro Re, MD, Arben Lleshi, MD, Maurizio Bonfichi, MD, Antonello Pinto, Nicola Bianchetti, Lisa Argnani, Pier Luigi Zinzani, MD

Blood (2018) 132 (Supplement 1): 2920.

https://doi.org/10.1182/blood-2018-99-111812

Published: 2018

Journal Articles

Five-Year Survival and Durability Results of the Phase 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine)As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Classic Hodgkin Lymphoma

Armando Santoro, MD, Rita Mazza, MD, Alessandro Pulsoni, MD, Alessandro Re, MD, Maurizio Bonfichi, MD, Vittorio Ruggero Zilioli, Flavia Salvi, Antonella Anastasia, MD, Stefano Luminari, MD, Manuel Gotti, MD, Annalisa Peli, MD, Anna Marina Liberati, MD, Nicola Di Renzo, MD, Luca Castagna, MD, Laura Giordano, Carmelo Carlo-Stella, MD

Blood (2018) 132 (Supplement 1): 1628.

https://doi.org/10.1182/blood-2018-99-118931

Published: 2018

Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Blood (2016) 128 (22): 3007.

https://doi.org/10.1182/blood.V128.22.3007.3007

Published: 2016

Journal Articles

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma

Blood (2016) 128 (22): 4161.

https://doi.org/10.1182/blood.V128.22.4161.4161

Published: 2016

Journal Articles

Remarkable Clinical Efficacy, Stem Cell Mobilization Activity and Good Toxicity Profile of the Novel Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) Used As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Armando Santoro, MD, Rita Mazza, MD, Alessandro Pulsoni, MD, Alessandro Re, Maurizio Bonfichi, MD, Vittorio Ruggero Zilioli, MD, Flavia Salvi, MD, Antonella Anastasia, Stefano Luminari, MD, Manuel Gotti, MD, Annalisa Peli, Anna Marina Liberati, MD, Nicola Di Renzo, Luca Castagna, Laura Giordano, Carmelo Carlo-Stella, MD

Blood (2015) 126 (23): 581.

https://doi.org/10.1182/blood.V126.23.581.581

Published: 2015

Journal Articles

Lower Leukocytosis with Biosimilar Compared with Originator G-CSF during Autologous Stem Cell Mobilization after Chemotherapy in Lymphoma and Multiple Myeloma Patients. a Pharmacovigilance Study of “Rete Ematologica Lombarda” (FARMA-REL)

Anna Maria Pelizzari, MD, Paola Tozzi, PharmD, Francesca Bocchio, Maurizio Bonfichi, Silvia Artuso, Nicola Fracchiolla, MD, Valentino Conti, Pierino Ferremi, Camillo Almici, MD, Daria Bettoni, Vincenza Orlando, PharmD, Giuseppe Rossi, MD, Giuliana Muti

Blood (2014) 124 (21): 5836.

https://doi.org/10.1182/blood.V124.21.5836.5836

Published: 2014

Journal Articles

Non-Hodgkin's Lymphomas Associated With Positive Hepatitis-C Virus Infection: A Prospective Multicentric Observational Study On Behalf Of The “Rete Ematologica Lombarda/Hematology Network Of Lombardia Region”

Sara Rattotti, Luca Arcaini, Virginia Valeria Ferretti, Andrea Rossi, Stefano Fogazzi, Antonino Greco, Luca Baldini, Monica Balzarotti, Pietro Pioltelli, Maurizio Bonfichi, Marzia Varettoni, Manuel Gotti, Lucia Farina, Andrés J.M. Ferreri, Daniele Laszlo, Enrica Morra, MD

Blood (2013) 122 (21): 3003.

https://doi.org/10.1182/blood.V122.21.3003.3003

Published: 2013

Journal Articles

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Marzia Varettoni, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, Ester Orlandi, Maurizio Bonfichi, Manuel Gotti, Cristiana Pascutto, Silvia Mangiacavalli, Giorgio Croci, Valeria Fiaccadori, Lucia Morello, Maria Luisa Guerrera, Marco Paulli, Mario Cazzola

Blood (2013) 121 (13): 2522–2528.

https://doi.org/10.1182/blood-2012-09-457101

Published: 2013

Journal Articles

Hierarchical Clustering of B-Cell Receptor Structures in Splenic Marginal Zone Lymphoma

Paolo Marcatili, Silvia Zibellini, Sara Rattotti, Anna Chailyan, Marzia Varettoni, Lucia Morello, Emanuela Boveri, Marco Lucioni, Maurizio Bonfichi, Manuel Gotti, Valeria Fiaccadori, Marco Paulli, Anna Tramontano, Luca Arcaini

Blood (2012) 120 (21): 1585.

https://doi.org/10.1182/blood.V120.21.1585.1585

Published: 2012

Journal Articles

Clinical Significance of Tumor-Associated Macrophages in Early-Stage Hodgkin's Lymphoma.

Manuel Gotti, Marta Nicola, Valeria Fiaccadori, Elisa Bono, Marco Lucioni, Maurizio Bonfichi, Marzia Varettoni, Cristiana Pascutto, Luca Arcaini, Marco Paulli, Mario Cazzola

Blood (2012) 120 (21): 2638.

https://doi.org/10.1182/blood.V120.21.2638.2638

Published: 2012

Journal Articles

Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenström Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms.

Marzia Varettoni, Luca Arcaini, Silvia Zibellini, Emanuela Boveri, Sara Rattotti, Roberta Riboni, Alessandro Corso, Ester Orlandi, Maurizio Bonfichi, Manuel Gotti, Cristiana Pascutto, Silvia Mangiacavalli, Lucia Morello, Maria Luisa Guerrera, Giorgio Croci, Valeria Fiaccadori, Marco Paulli, Mario Cazzola

Blood (2012) 120 (21): 2667.

https://doi.org/10.1182/blood.V120.21.2667.2667

Published: 2012

Journal Articles

Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers

Blood (2010) 116 (21): 966.

https://doi.org/10.1182/blood.V116.21.966.966

Published: 2010

Journal Articles

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.

Blood (2009) 114 (22): 1713.

https://doi.org/10.1182/blood.V114.22.1713.1713

Published: 2009

Journal Articles

Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim.

Maurizio Bonfichi, MD, Ercole Brusamolino, MD, Carmela Marseglia, BS, Chiara Rusconi, MD, Mario Lazzarino, MD

Blood (2005) 106 (11): 4245.

https://doi.org/10.1182/blood.V106.11.4245.4245

Published: 2005

NARROW

Molecular Characterization of Diffuse Large B-Cell Lymphoma Associated to Hepatitis C Virus Infection

Cell-of-Origin Identification and Prognostic Correlation in HIV-Associated Diffuse Large B-Cell Lymphomas: Results of an Italian Multicentric Study

A Phase II Study of Brentuximab Vedotin (BV) in the Treatment of Elderly Hodgkin Lymphoma (HL) Patients at First Relapse or with Primary Refractory Disease — FIL_BVHD01

Five-Year Survival and Durability Results of the Phase 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine)As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Classic Hodgkin Lymphoma

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Anaplastic Large Cell Lymphoma

Italian Real Life Experience with Brentuximab Vedotin: Results of a National Observational Study on Relapsed/Refractory Hodgkin's Lymphoma

Remarkable Clinical Efficacy, Stem Cell Mobilization Activity and Good Toxicity Profile of the Novel Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) Used As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Lower Leukocytosis with Biosimilar Compared with Originator G-CSF during Autologous Stem Cell Mobilization after Chemotherapy in Lymphoma and Multiple Myeloma Patients. a Pharmacovigilance Study of “Rete Ematologica Lombarda” (FARMA-REL)

Non-Hodgkin's Lymphomas Associated With Positive Hepatitis-C Virus Infection: A Prospective Multicentric Observational Study On Behalf Of The “Rete Ematologica Lombarda/Hematology Network Of Lombardia Region”

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenström’s macroglobulinemia and related lymphoid neoplasms

Hierarchical Clustering of B-Cell Receptor Structures in Splenic Marginal Zone Lymphoma

Clinical Significance of Tumor-Associated Macrophages in Early-Stage Hodgkin's Lymphoma.

Prevalence and Clinical Significance of the MYD88 (L265P) Somatic Mutation in Patients with Waldenström Macroglobulinemia, IgM-Monoclonal Gammopathy of Undetermined Significance or Other Mature B-Cell Neoplasms.

Salvage Treatment with Lenalidomide and Dexamethasone In Patients with Relapsed Refractory Mantle Cell Lymphoma: Clinical Results and Modifications of Angiogenic Biomarkers

Salvage Treatment with Lenalidomide and Dexamethasone in Patients with Relapsed Refractory Mantle Cell Lymphoma.

Evaluation of Progenitor Cells (CFU-GM, CFU-GEMM, BFU-E, CD34+ Cells) and White Blood Cells in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Rituximab-CHOP-14 and Supported with Pegfilgrastim.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only